Back

An inducible genetic model of chronic hypoxic signaling in cardiomyocytes precipitates severe cardiomyopathy and remodeling.

Phillips, C. M.; Zeitz, M. J.; Sapp, E. H.; Abouelenein, K. M.; Smyth, J. W.

2025-04-15 pathology
10.1101/2025.04.09.647295 bioRxiv
Show abstract

Cardiovascular disease remains the leading cause of death globally, underscoring the need for physiologically relevant models to investigate mechanisms of heart failure and arrhythmia. Chronic activation of hypoxic signaling pathways, particularly via the hypoxia-inducible factor (HIF) axis, is a key contributor to cardiac remodeling under stress. A major regulator of HIF signaling is the von Hippel-Lindau tumor suppressor (VHL) which, under normoxic conditions, targets HIF for proteasomal degradation. Loss of VHL results in HIF accumulation and persistent hypoxic signaling, but constitutive cardiomyocyte-specific Vhl knockout models are confounded by developmental effects and early mortality. Here, we develop and characterize an inducible, cardiomyocyte-specific Vhl knockout mouse model as a non-invasive and temporally controlled system to study chronic hypoxic stress and its contribution to cardiac remodeling and disease. VhlLoxP/LoxP;MHC-MerCreMer+/- mice were administered tamoxifen to induce Vhl deletion in adult cardiomyocytes. Within 5-7 days post-induction, mice displayed reduced ejection fraction, increased cardiac diameter, and elevated expression of cardiac stress markers. Transcriptomic and protein analyses revealed downregulation of key genes involved in cardiac structure and electrophysiology, including Gja1 (Cx43), Cdh2 (N-cadherin), Cacna1c (CaV1.2), and Kcnq1. Importantly, these changes preceded overt cardiac remodeling, as confirmed in an abbreviated tamoxifen protocol. This inducible Vhl knockout model recapitulates hallmark features of dilated cardiomyopathy and highlights a subset of cardiac structural and ion channel genes as sensitive early responders to chronic hypoxic stress. This platform enables mechanistic dissection of disease onset and progression in ischemic heart disease and serves as a well-controlled and reproducible model for evaluating novel therapeutic strategies.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
Circulation Research
47 papers in training set
Top 0.1%
26.4%
2
eLife
5828 papers in training set
Top 10%
9.6%
3
Cardiovascular Research
37 papers in training set
Top 0.1%
7.2%
4
Circulation
74 papers in training set
Top 0.4%
7.2%
50% of probability mass above
5
Circulation: Heart Failure
14 papers in training set
Top 0.1%
6.7%
6
JCI Insight
277 papers in training set
Top 1%
5.4%
7
Journal of the American Heart Association
140 papers in training set
Top 1%
5.4%
8
American Journal of Physiology-Heart and Circulatory Physiology
36 papers in training set
Top 0.4%
3.2%
9
Scientific Reports
3612 papers in training set
Top 44%
2.4%
10
Journal of Molecular and Cellular Cardiology
40 papers in training set
Top 0.4%
1.7%
11
Nature Communications
5641 papers in training set
Top 45%
1.7%
12
iScience
1154 papers in training set
Top 20%
1.5%
13
The FASEB Journal
194 papers in training set
Top 3%
1.5%
14
Disease Models & Mechanisms
119 papers in training set
Top 1%
1.4%
15
International Journal of Molecular Sciences
494 papers in training set
Top 10%
1.3%
16
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 35%
1.1%
17
PLOS ONE
5266 papers in training set
Top 59%
1.0%
18
Cells
249 papers in training set
Top 9%
0.6%
19
FASEB BioAdvances
18 papers in training set
Top 0.5%
0.6%
20
Arteriosclerosis, Thrombosis, and Vascular Biology
71 papers in training set
Top 1%
0.6%
21
Cell Reports
1498 papers in training set
Top 29%
0.6%
22
JACC: Basic to Translational Science
21 papers in training set
Top 0.9%
0.6%